Table IV.
Mean (SEM) changes in abdominal fat distribution versus baseline in patients who completed the study (N = 39). (Values are expressed as % unless otherwise noted.)
| All Subjects |
Men |
Women |
|||||||
|---|---|---|---|---|---|---|---|---|---|
| Fat Distribution/ Study Week | Garciniacambogia Group (n = 18) | Placebo Group (n = 21) | P∗ | Garciniacambogia Group (n = 8) | Placebo Group (n = 11) | P∗ | Garciniacambogia Group(n = 10) | Placebo Group (n = 10) | P∗ |
| Visceral fat area | |||||||||
| Week 0, mean (SEM), cm2 | 146.2 (9.9) | 144.9 (7.5) | – | 156.2 (13.5) | 142.2 (8.1) | – | 138.2 (14.4) | 147.9 (13.6) | – |
| Week 12 | 89.2 (2.5) | 105.1 (3.2) | 0.009 | 87.8 (4.6) | 105.5 (5.5) | 0.032 | 90.2 (2.9) | 104.8 (3.2) | 0.003 |
| Week 16 | 86.4 (2.1) | 106.9 (3.8) | 0.001 | 82.3 (3.5) | 107.2 (5.9) | 0.004 | 89.7 (2.3) | 106.5 (5.2) | 0.004 |
| Subcutaneous fat area | |||||||||
| Week 0, mean (SEM), cm2 | 231.3 (20.2) | 223.4 (20.2) | – | 170.9 (22.7) | 171.5 (18.6) | – | 279.6 (21.9) | 280.4 (28.2) | – |
| Week 12 | 87.6 (2.4) | 106.7 (3.1) | 0.003 | 90.1 (2.7) | 107.0 (5.0) | 0.017 | 85.6 (3.8) | 106.3 (3.9) | 0.001 |
| Week 16 | 85.4 (3.1) | 108.0 (2.6) | <0.001 | 88.9 (3.9) | 110.5 (3.3) | <0.001 | 82.5 (4.7) | 110.5 (3.3) | <0.001 |
| Total fat area | |||||||||
| Week 0, mean (SEM), cm2 | 379.2 (21.9) | 367.9 (22.4) | – | 334.6 (32.9) | 313.3 (17.8) | – | 414.9 (25.1) | 427.9 (34.4) | – |
| Week 12 | 87.7 (1.6) | 105.6 (2.2) | <0.001 | 87.8 (2.6) | 105.6 (3.4) | 0.001 | 87.6 (2.2) | 105.6 (3.4) | <0.001 |
| Week 16 | 85.2 (2.3) | 106.3 (2.2) | <0.001 | 84.8 (2.9) | 107.7 (3.4) | <0.001 | 85.5 (3.6) | 104.7 (2.7) | <0.001 |
∗
Between-group difference.